title: beta-Agonist tocolytic therapy.
abstract: With the advent of preterm birth prevention programs, increasing numbers of patients are now considered candidates for tocolytic management. Tocolysis' chief benefit is significantly prolonging pregnancy in the hope of avoiding or ameliorating the sequelae of preterm delivery. Three principal indications dominate the use of tocolysis in the treatment of preterm labor: (1) prophylaxis, (2) acute therapy, and (3) maintenance.
authors.affiliation: Department of Obstetrics and Gynecology, California Pacific Medical Center, San Francisco, 94118, USA. funglamMD@aol.com
authors.forename: Fung
authors.initials: F
authors.lastname: Lam
authors.forename: Pamela
authors.initials: P
authors.lastname: Gill
mesh_terms: D000318:Adrenergic beta-Agonists / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D015918:Infusion Pumps, Implantable; D007752:Obstetric Labor, Premature / Q000188:drug therapy*; D011247:Pregnancy; D013726:Terbutaline / Q000008:administration & dosage; D015149:Tocolytic Agents / Q000627:therapeutic use*
chemical_list: D000318:Adrenergic beta-Agonists; D015149:Tocolytic Agents; D013726:Terbutaline